New Wave

Mental Health

Projected global market for mental health / neurological disorders by 2025:

$128.9B

Scientific evidence is revealing a better path.

New research is emerging to reinforce the idea that psychedelic compounds have the potential to produce more effective mental health treatment options than the pharmaceutical products currently in use.

Leading global institutions have indicated that psilocybin-assisted therapy could be a revolutionary treatment for:

The FDA has granted “breakthrough therapy” status to further the study of psilocybin and ketamine remedies.

IP Development

The company is building a scientific advisory board to expedite the development of New Wave’s psychedelic medical research portfolio.

Just how pervasive are mental health issues?

Take a look at the US alone:

Invest with us

Download our investor presentation to learn more about New Wave Holding and the opportunities ahead.

Connect with us

Want to know more? Reach out to us today.